June 17, 2021
Breakthrough T1D Statement on the U.S. Supreme Court Affordable Care Act Ruling
June 10, 2021
Statement from Breakthrough T1D Vice President of Research, Sanjoy Dutta, Ph.D., on the appointment of Kevan Herold, M.D., to TrialNet Chair
June 2, 2021
Breakthrough T1D Chair Premier Panel at 2021 Advanced Technologies & Treatments for Diabetes Conference Featuring Provention Bio, ViaCyte and vTv Therapeutics
May 27, 2021
Breakthrough T1D Statement on FDA Advisory Committee Recommendation of Teplizumab
May 20, 2021
Breakthrough T1D Celebrates Global Accessibility Awareness Day Spotlighting Accessibility Features to Breakthrough T1D.org
May 19, 2021
Breakthrough T1D Statement on FDA Authorization of the Pfizer-BioNTech Covid-19 Vaccine for Youth Ages 12–15
May 10, 2021
Breakthrough T1D Official Statement on Bigfoot Unity™ Diabetes Management FDA Clearance
April 27, 2021
Breakthrough T1D Celebrates the Strength of the T1D Community at the TypeOneNation Virtual Summit
March 30, 2021
Breakthrough T1D Statement on CDC Update of Covid-19 Prioritization Guidelines
February 24, 2021
Breakthrough T1D, Lupus Research Alliance and National Multiple Sclerosis Society Join Forces to Decode Common Mechanisms of Autoimmune Diseases
